JP5540102B2 - 高められた病理学的決定のための複数モダリティコントラストおよび明視野コンテキスト表現、および組織内の複数検体検出 - Google Patents
高められた病理学的決定のための複数モダリティコントラストおよび明視野コンテキスト表現、および組織内の複数検体検出 Download PDFInfo
- Publication number
- JP5540102B2 JP5540102B2 JP2012533322A JP2012533322A JP5540102B2 JP 5540102 B2 JP5540102 B2 JP 5540102B2 JP 2012533322 A JP2012533322 A JP 2012533322A JP 2012533322 A JP2012533322 A JP 2012533322A JP 5540102 B2 JP5540102 B2 JP 5540102B2
- Authority
- JP
- Japan
- Prior art keywords
- image
- contrast
- images
- color
- specimen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000001514 detection method Methods 0.000 title description 15
- 230000001575 pathological effect Effects 0.000 title description 13
- 238000000034 method Methods 0.000 claims description 65
- 238000003384 imaging method Methods 0.000 claims description 59
- 230000003287 optical effect Effects 0.000 claims description 39
- 230000005284 excitation Effects 0.000 claims description 38
- WZUVPPKBWHMQCE-UHFFFAOYSA-N Haematoxylin Chemical compound C12=CC(O)=C(O)C=C2CC2(O)C1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-UHFFFAOYSA-N 0.000 claims description 37
- YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 claims description 22
- 238000013507 mapping Methods 0.000 claims description 21
- 239000000975 dye Substances 0.000 claims description 20
- 239000007850 fluorescent dye Substances 0.000 claims description 13
- 238000002073 fluorescence micrograph Methods 0.000 claims description 10
- 238000001454 recorded image Methods 0.000 claims description 9
- 230000008569 process Effects 0.000 claims description 5
- 210000001519 tissue Anatomy 0.000 description 100
- 239000000523 sample Substances 0.000 description 70
- FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 45
- 238000005286 illumination Methods 0.000 description 43
- 239000002096 quantum dot Substances 0.000 description 32
- 238000012545 processing Methods 0.000 description 29
- 230000000295 complement effect Effects 0.000 description 26
- 238000010186 staining Methods 0.000 description 25
- 230000000875 corresponding effect Effects 0.000 description 18
- 239000000126 substance Substances 0.000 description 15
- 238000005259 measurement Methods 0.000 description 13
- 230000003595 spectral effect Effects 0.000 description 13
- 238000006243 chemical reaction Methods 0.000 description 12
- 108020004999 messenger RNA Proteins 0.000 description 12
- 238000002360 preparation method Methods 0.000 description 12
- 108090000623 proteins and genes Proteins 0.000 description 12
- 238000013459 approach Methods 0.000 description 11
- 238000004949 mass spectrometry Methods 0.000 description 10
- 102000004169 proteins and genes Human genes 0.000 description 10
- 238000007901 in situ hybridization Methods 0.000 description 9
- 230000005855 radiation Effects 0.000 description 9
- 238000012800 visualization Methods 0.000 description 9
- 238000004458 analytical method Methods 0.000 description 8
- 230000000877 morphologic effect Effects 0.000 description 8
- 239000002105 nanoparticle Substances 0.000 description 8
- 238000003745 diagnosis Methods 0.000 description 7
- 238000011156 evaluation Methods 0.000 description 7
- 238000003364 immunohistochemistry Methods 0.000 description 7
- 108020004414 DNA Proteins 0.000 description 6
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 6
- 238000010521 absorption reaction Methods 0.000 description 6
- 102000036639 antigens Human genes 0.000 description 6
- 108091007433 antigens Proteins 0.000 description 6
- 239000003086 colorant Substances 0.000 description 6
- 239000011159 matrix material Substances 0.000 description 6
- 230000007170 pathology Effects 0.000 description 6
- 238000003860 storage Methods 0.000 description 6
- 238000011282 treatment Methods 0.000 description 6
- 241000699666 Mus <mouse, genus> Species 0.000 description 5
- 206010028980 Neoplasm Diseases 0.000 description 5
- 201000011510 cancer Diseases 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 238000010586 diagram Methods 0.000 description 5
- 230000009977 dual effect Effects 0.000 description 5
- 238000002372 labelling Methods 0.000 description 5
- 238000012549 training Methods 0.000 description 5
- 230000002159 abnormal effect Effects 0.000 description 4
- 239000000427 antigen Substances 0.000 description 4
- 230000027455 binding Effects 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 230000004907 flux Effects 0.000 description 4
- 230000007773 growth pattern Effects 0.000 description 4
- 238000001871 ion mobility spectroscopy Methods 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000003068 molecular probe Substances 0.000 description 4
- 210000002307 prostate Anatomy 0.000 description 4
- 210000005084 renal tissue Anatomy 0.000 description 4
- 230000009870 specific binding Effects 0.000 description 4
- 230000009466 transformation Effects 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 3
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 3
- 206010060862 Prostate cancer Diseases 0.000 description 3
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- XJMXIWNOKIEIMX-UHFFFAOYSA-N bromo chloro 1h-indol-2-yl phosphate Chemical compound C1=CC=C2NC(OP(=O)(OBr)OCl)=CC2=C1 XJMXIWNOKIEIMX-UHFFFAOYSA-N 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000000701 chemical imaging Methods 0.000 description 3
- 238000000151 deposition Methods 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 210000002744 extracellular matrix Anatomy 0.000 description 3
- 239000003446 ligand Substances 0.000 description 3
- 230000031700 light absorption Effects 0.000 description 3
- 230000004807 localization Effects 0.000 description 3
- 239000003550 marker Substances 0.000 description 3
- 238000000816 matrix-assisted laser desorption--ionisation Methods 0.000 description 3
- JPXMTWWFLBLUCD-UHFFFAOYSA-N nitro blue tetrazolium(2+) Chemical compound COC1=CC(C=2C=C(OC)C(=CC=2)[N+]=2N(N=C(N=2)C=2C=CC=CC=2)C=2C=CC(=CC=2)[N+]([O-])=O)=CC=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=C([N+]([O-])=O)C=C1 JPXMTWWFLBLUCD-UHFFFAOYSA-N 0.000 description 3
- 238000005457 optimization Methods 0.000 description 3
- 210000002741 palatine tonsil Anatomy 0.000 description 3
- 230000002093 peripheral effect Effects 0.000 description 3
- GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 description 2
- LVSPDZAGCBEQAV-UHFFFAOYSA-N 4-chloronaphthalen-1-ol Chemical compound C1=CC=C2C(O)=CC=C(Cl)C2=C1 LVSPDZAGCBEQAV-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 102100022005 B-lymphocyte antigen CD20 Human genes 0.000 description 2
- 108091006146 Channels Proteins 0.000 description 2
- 108010077544 Chromatin Proteins 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 101000897405 Homo sapiens B-lymphocyte antigen CD20 Proteins 0.000 description 2
- 101001012157 Homo sapiens Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 description 2
- 102000009875 Ki-67 Antigen Human genes 0.000 description 2
- 108010020437 Ki-67 Antigen Proteins 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- 102100030086 Receptor tyrosine-protein kinase erbB-2 Human genes 0.000 description 2
- WLDHEUZGFKACJH-UHFFFAOYSA-K amaranth Chemical compound [Na+].[Na+].[Na+].C12=CC=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(O)=C1N=NC1=CC=C(S([O-])(=O)=O)C2=CC=CC=C12 WLDHEUZGFKACJH-UHFFFAOYSA-K 0.000 description 2
- 210000003484 anatomy Anatomy 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 210000003483 chromatin Anatomy 0.000 description 2
- 230000001427 coherent effect Effects 0.000 description 2
- 238000004891 communication Methods 0.000 description 2
- 239000000994 contrast dye Substances 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000000295 emission spectrum Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000001917 fluorescence detection Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000007274 generation of a signal involved in cell-cell signaling Effects 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 229910052736 halogen Inorganic materials 0.000 description 2
- 238000009396 hybridization Methods 0.000 description 2
- 238000002513 implantation Methods 0.000 description 2
- 230000010354 integration Effects 0.000 description 2
- JORABGDXCIBAFL-UHFFFAOYSA-M iodonitrotetrazolium chloride Chemical compound [Cl-].C1=CC([N+](=O)[O-])=CC=C1N1[N+](C=2C=CC(I)=CC=2)=NC(C=2C=CC=CC=2)=N1 JORABGDXCIBAFL-UHFFFAOYSA-M 0.000 description 2
- 239000003607 modifier Substances 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 239000012188 paraffin wax Substances 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 230000008447 perception Effects 0.000 description 2
- 230000010363 phase shift Effects 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 230000011218 segmentation Effects 0.000 description 2
- 239000004065 semiconductor Substances 0.000 description 2
- 239000004054 semiconductor nanocrystal Substances 0.000 description 2
- 238000004088 simulation Methods 0.000 description 2
- 230000000153 supplemental effect Effects 0.000 description 2
- GZCWLCBFPRFLKL-UHFFFAOYSA-N 1-prop-2-ynoxypropan-2-ol Chemical compound CC(O)COCC#C GZCWLCBFPRFLKL-UHFFFAOYSA-N 0.000 description 1
- 108020004463 18S ribosomal RNA Proteins 0.000 description 1
- KLLLJCACIRKBDT-UHFFFAOYSA-N 2-phenyl-1H-indole Chemical compound N1C2=CC=CC=C2C=C1C1=CC=CC=C1 KLLLJCACIRKBDT-UHFFFAOYSA-N 0.000 description 1
- JRBJSXQPQWSCCF-UHFFFAOYSA-N 3,3'-Dimethoxybenzidine Chemical compound C1=C(N)C(OC)=CC(C=2C=C(OC)C(N)=CC=2)=C1 JRBJSXQPQWSCCF-UHFFFAOYSA-N 0.000 description 1
- XZKIHKMTEMTJQX-UHFFFAOYSA-N 4-Nitrophenyl Phosphate Chemical compound OP(O)(=O)OC1=CC=C([N+]([O-])=O)C=C1 XZKIHKMTEMTJQX-UHFFFAOYSA-N 0.000 description 1
- AXDJCCTWPBKUKL-UHFFFAOYSA-N 4-[(4-aminophenyl)-(4-imino-3-methylcyclohexa-2,5-dien-1-ylidene)methyl]aniline;hydron;chloride Chemical compound Cl.C1=CC(=N)C(C)=CC1=C(C=1C=CC(N)=CC=1)C1=CC=C(N)C=C1 AXDJCCTWPBKUKL-UHFFFAOYSA-N 0.000 description 1
- YRNWIFYIFSBPAU-UHFFFAOYSA-N 4-[4-(dimethylamino)phenyl]-n,n-dimethylaniline Chemical compound C1=CC(N(C)C)=CC=C1C1=CC=C(N(C)C)C=C1 YRNWIFYIFSBPAU-UHFFFAOYSA-N 0.000 description 1
- OPIFSICVWOWJMJ-AEOCFKNESA-N 5-bromo-4-chloro-3-indolyl beta-D-galactoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=CNC2=CC=C(Br)C(Cl)=C12 OPIFSICVWOWJMJ-AEOCFKNESA-N 0.000 description 1
- DHJFFLKPAYHPHU-BYNIDDHOSA-N 5-bromo-4-chloro-3-indolyl beta-D-glucuronide Chemical compound O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC1=CNC2=CC=C(Br)C(Cl)=C12 DHJFFLKPAYHPHU-BYNIDDHOSA-N 0.000 description 1
- JXCKZXHCJOVIAV-UHFFFAOYSA-N 6-[(5-bromo-4-chloro-1h-indol-3-yl)oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid;cyclohexanamine Chemical compound [NH3+]C1CCCCC1.O1C(C([O-])=O)C(O)C(O)C(O)C1OC1=CNC2=CC=C(Br)C(Cl)=C12 JXCKZXHCJOVIAV-UHFFFAOYSA-N 0.000 description 1
- OXEUETBFKVCRNP-UHFFFAOYSA-N 9-ethyl-3-carbazolamine Chemical compound NC1=CC=C2N(CC)C3=CC=CC=C3C2=C1 OXEUETBFKVCRNP-UHFFFAOYSA-N 0.000 description 1
- 102000013563 Acid Phosphatase Human genes 0.000 description 1
- 108010051457 Acid Phosphatase Proteins 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 239000004971 Cross linker Substances 0.000 description 1
- 239000003298 DNA probe Substances 0.000 description 1
- 108090000204 Dipeptidase 1 Proteins 0.000 description 1
- 108050001049 Extracellular proteins Proteins 0.000 description 1
- 108010015776 Glucose oxidase Proteins 0.000 description 1
- 239000004366 Glucose oxidase Substances 0.000 description 1
- 102000053187 Glucuronidase Human genes 0.000 description 1
- 108010060309 Glucuronidase Proteins 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 101000694017 Homo sapiens Sodium channel protein type 5 subunit alpha Proteins 0.000 description 1
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 1
- 102000004856 Lectins Human genes 0.000 description 1
- 108090001090 Lectins Proteins 0.000 description 1
- 108010052285 Membrane Proteins Proteins 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- SXEHKFHPFVVDIR-UHFFFAOYSA-N [4-(4-hydrazinylphenyl)phenyl]hydrazine Chemical compound C1=CC(NN)=CC=C1C1=CC=C(NN)C=C1 SXEHKFHPFVVDIR-UHFFFAOYSA-N 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000003044 adaptive effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- 238000000149 argon plasma sintering Methods 0.000 description 1
- OHDRQQURAXLVGJ-HLVWOLMTSA-N azane;(2e)-3-ethyl-2-[(e)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound [NH4+].[NH4+].S/1C2=CC(S([O-])(=O)=O)=CC=C2N(CC)C\1=N/N=C1/SC2=CC(S([O-])(=O)=O)=CC=C2N1CC OHDRQQURAXLVGJ-HLVWOLMTSA-N 0.000 description 1
- JXLHNMVSKXFWAO-UHFFFAOYSA-N azane;7-fluoro-2,1,3-benzoxadiazole-4-sulfonic acid Chemical compound N.OS(=O)(=O)C1=CC=C(F)C2=NON=C12 JXLHNMVSKXFWAO-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 102000005936 beta-Galactosidase Human genes 0.000 description 1
- 108010005774 beta-Galactosidase Proteins 0.000 description 1
- 102000006635 beta-lactamase Human genes 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 230000004397 blinking Effects 0.000 description 1
- UHYPYGJEEGLRJD-UHFFFAOYSA-N cadmium(2+);selenium(2-) Chemical compound [Se-2].[Cd+2] UHYPYGJEEGLRJD-UHFFFAOYSA-N 0.000 description 1
- 239000003990 capacitor Substances 0.000 description 1
- 238000001444 catalytic combustion detection Methods 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 210000003855 cell nucleus Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 125000003636 chemical group Chemical group 0.000 description 1
- 238000001148 chemical map Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000008711 chromosomal rearrangement Effects 0.000 description 1
- 239000012459 cleaning agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000004590 computer program Methods 0.000 description 1
- 239000002872 contrast media Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 238000010219 correlation analysis Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 238000005138 cryopreservation Methods 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 238000013500 data storage Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 101150113316 egr gene Proteins 0.000 description 1
- 230000002327 eosinophilic effect Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000000834 fixative Substances 0.000 description 1
- 238000000799 fluorescence microscopy Methods 0.000 description 1
- 238000012632 fluorescent imaging Methods 0.000 description 1
- 238000001215 fluorescent labelling Methods 0.000 description 1
- 239000002529 flux (metallurgy) Substances 0.000 description 1
- 230000008570 general process Effects 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229940116332 glucose oxidase Drugs 0.000 description 1
- 235000019420 glucose oxidase Nutrition 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 238000003365 immunocytochemistry Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000001698 laser desorption ionisation Methods 0.000 description 1
- 229940056932 lead sulfide Drugs 0.000 description 1
- 229910052981 lead sulfide Inorganic materials 0.000 description 1
- 239000002523 lectin Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 238000001840 matrix-assisted laser desorption--ionisation time-of-flight mass spectrometry Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000005055 memory storage Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- 238000009660 micro-sectioning Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000007479 molecular analysis Methods 0.000 description 1
- 238000001451 molecular beam epitaxy Methods 0.000 description 1
- 239000003147 molecular marker Substances 0.000 description 1
- AFRBPRLOPBAGCM-UHFFFAOYSA-N n-[2-(1h-indol-4-yl)ethyl]-n-propylpropan-1-amine Chemical compound CCCN(CCC)CCC1=CC=CC2=C1C=CN2 AFRBPRLOPBAGCM-UHFFFAOYSA-N 0.000 description 1
- 210000000633 nuclear envelope Anatomy 0.000 description 1
- 238000012758 nuclear staining Methods 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 210000004940 nucleus Anatomy 0.000 description 1
- 238000012634 optical imaging Methods 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 230000010287 polarization Effects 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 208000021046 prostate intraepithelial neoplasia Diseases 0.000 description 1
- 238000011471 prostatectomy Methods 0.000 description 1
- 238000004451 qualitative analysis Methods 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 238000011158 quantitative evaluation Methods 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 108020004418 ribosomal RNA Proteins 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000010183 spectrum analysis Methods 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- MUUHXGOJWVMBDY-UHFFFAOYSA-L tetrazolium blue Chemical compound [Cl-].[Cl-].COC1=CC(C=2C=C(OC)C(=CC=2)[N+]=2N(N=C(N=2)C=2C=CC=CC=2)C=2C=CC=CC=2)=CC=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=CC=C1 MUUHXGOJWVMBDY-UHFFFAOYSA-L 0.000 description 1
- RONADMZTCCPLEF-UHFFFAOYSA-M tetrazolium violet Chemical compound [Cl-].C1=CC=CC=C1C(N=[N+]1C=2C3=CC=CC=C3C=CC=2)=NN1C1=CC=CC=C1 RONADMZTCCPLEF-UHFFFAOYSA-M 0.000 description 1
- 210000003813 thumb Anatomy 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 229910052721 tungsten Inorganic materials 0.000 description 1
- 239000010937 tungsten Substances 0.000 description 1
- -1 tungsten halogen Chemical class 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/645—Specially adapted constructive features of fluorimeters
- G01N21/6456—Spatial resolved fluorescence measurements; Imaging
Landscapes
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physics & Mathematics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25080909P | 2009-10-12 | 2009-10-12 | |
| US61/250,809 | 2009-10-12 | ||
| US27893609P | 2009-10-13 | 2009-10-13 | |
| US61/278,936 | 2009-10-13 | ||
| PCT/US2010/051857 WO2011046807A2 (en) | 2009-10-12 | 2010-10-07 | Multi-modality contrast and brightfield context rendering for enhanced pathology determination and multi-analyte detection in tissue |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013507612A JP2013507612A (ja) | 2013-03-04 |
| JP5540102B2 true JP5540102B2 (ja) | 2014-07-02 |
Family
ID=43876802
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012533322A Expired - Fee Related JP5540102B2 (ja) | 2009-10-12 | 2010-10-07 | 高められた病理学的決定のための複数モダリティコントラストおよび明視野コンテキスト表現、および組織内の複数検体検出 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US9310302B2 (enExample) |
| EP (1) | EP2488860A4 (enExample) |
| JP (1) | JP5540102B2 (enExample) |
| KR (1) | KR101388291B1 (enExample) |
| CN (1) | CN102667473B (enExample) |
| AU (1) | AU2010307140B2 (enExample) |
| CA (1) | CA2774422C (enExample) |
| IL (1) | IL218553B (enExample) |
| IN (1) | IN2012DN02337A (enExample) |
| WO (1) | WO2011046807A2 (enExample) |
Families Citing this family (69)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9767550B2 (en) * | 2010-12-13 | 2017-09-19 | Koninklijke Philips N.V. | Method and device for analysing a region of interest in an object using x-rays |
| US8639013B2 (en) * | 2011-08-17 | 2014-01-28 | General Electric Company | System and methods for generating a brightfield image using fluorescent images |
| JP5826561B2 (ja) * | 2011-08-24 | 2015-12-02 | オリンパス株式会社 | 顕微鏡システム、標本画像生成方法及びプログラム |
| JP5784435B2 (ja) * | 2011-09-20 | 2015-09-24 | オリンパス株式会社 | 画像処理装置、蛍光顕微鏡装置および画像処理プログラム |
| CN102426124B (zh) * | 2011-11-08 | 2013-07-03 | 中国人民解放军第四军医大学 | 用于病理组织冰冻切片的捞片展片装置及方法 |
| SG193046A1 (en) * | 2012-02-23 | 2013-09-30 | Histoindex Pte Ltd | A digital imaging system for biopsy inspection |
| US9194800B2 (en) * | 2012-10-29 | 2015-11-24 | Tokitae Llc | Systems, devices, and methods employing angular-resolved scattering and spectrally resolved measurements for classification of objects |
| KR20150094618A (ko) * | 2012-12-06 | 2015-08-19 | 클래리언트 다이아그노스틱 서비시즈, 인크. | 생물학적 시편의 분할 스크린 디스플레이와 그 레코드를 포착하기 위한 시스템 및 방법 |
| RU2012156158A (ru) * | 2012-12-24 | 2014-07-10 | ЭлЭсАй Корпорейшн | Генерация целевого изображения с использованием функционала на основе функций от информации из других изображений |
| JP6503335B2 (ja) * | 2013-03-12 | 2019-04-17 | サイトヴィヴァ， インコーポレイテッド | 生物学的な及び非生物学的な媒質でナノ粒子の位置を特定するための３次元画像処理 |
| US9786050B2 (en) * | 2013-03-15 | 2017-10-10 | The Board Of Trustees Of The University Of Illinois | Stain-free histopathology by chemical imaging |
| CN113349707A (zh) | 2013-12-31 | 2021-09-07 | 纪念斯隆-凯特琳癌症中心 | 用于荧光源实时多通道成像的系统、方法和设备 |
| TW201546486A (zh) * | 2014-06-11 | 2015-12-16 | Univ Nat Cheng Kung | 利用數位微型反射鏡元件之多光子螢光激發顯微裝置 |
| GB2528283B (en) | 2014-07-16 | 2020-08-05 | Barco Nv | Image colour calibration with multiple colour scales |
| JP6531403B2 (ja) * | 2015-01-27 | 2019-06-19 | 株式会社ニコン | 顕微鏡 |
| EP3268739B8 (en) * | 2015-03-11 | 2023-10-11 | The General Hospital Corporation | Plasmonic nanoparticle immunoassay method |
| US10672505B2 (en) | 2015-06-03 | 2020-06-02 | General Electric Company | Biological data annotation and visualization |
| US9953133B2 (en) | 2015-06-03 | 2018-04-24 | General Electric Company | Biological data annotation and visualization |
| WO2016201186A1 (en) * | 2015-06-11 | 2016-12-15 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Systems and methods for finding regions of interest in hematoxylin and eosin (h&e) stained tissue images and quantifying intratumor cellular spatial heterogeneity in multiplexed/hyperplexed fluorescence tissue images |
| JP6451845B2 (ja) * | 2015-06-16 | 2019-01-16 | コニカミノルタ株式会社 | 病理標本の蛍光画像の取得方法 |
| CN106338423B (zh) | 2015-07-10 | 2020-07-14 | 三斯坎公司 | 组织学染色的空间复用 |
| WO2017060954A1 (ja) | 2015-10-05 | 2017-04-13 | オリンパス株式会社 | 撮像装置 |
| JP6703824B2 (ja) | 2015-11-30 | 2020-06-03 | シスメックス株式会社 | 細胞選択方法、細胞検出方法、細胞選択装置、および細胞検出装置 |
| JP6597316B2 (ja) * | 2016-01-06 | 2019-10-30 | コニカミノルタ株式会社 | 画像処理装置及びプログラム |
| US10761027B2 (en) * | 2016-01-19 | 2020-09-01 | Konica Minolta, Inc. | Image processing apparatus and computer-readable recording medium storing program |
| CN108885210B (zh) | 2016-02-05 | 2022-07-19 | 纳诺韦尔生物科学有限公司 | 具有表面标记物的外来体的检测 |
| MA43593A (fr) | 2016-02-08 | 2018-11-14 | Imago Systems Inc | Système et procédé de visualisation et de caractérisation d'objets dans des images |
| US10825195B2 (en) * | 2016-04-06 | 2020-11-03 | Hoffman-La Roche, Inc. | Spatial index creation for IHC image analysis |
| JP6755975B2 (ja) * | 2016-06-10 | 2020-09-16 | エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト | 明視野像シミュレーションのためのシステム |
| EP3264741A1 (en) * | 2016-06-30 | 2018-01-03 | Thomson Licensing | Plenoptic sub aperture view shuffling with improved resolution |
| US10324041B2 (en) | 2016-12-21 | 2019-06-18 | Abbott Japan Co., Ltd. | Optical imaging system using lateral illumination for digital assays |
| US11047854B2 (en) | 2017-02-06 | 2021-06-29 | Abbott Japan Llc | Methods for reducing noise in signal-generating digital assays |
| US10580130B2 (en) * | 2017-03-24 | 2020-03-03 | Curadel, LLC | Tissue identification by an imaging system using color information |
| TWI654443B (zh) * | 2017-06-05 | 2019-03-21 | 銳準醫光股份有限公司 | 採用進階光學干涉顯微術之光學切層裝置 |
| JP7014794B2 (ja) | 2017-07-11 | 2022-02-01 | 浜松ホトニクス株式会社 | 試料観察装置及び試料観察方法 |
| WO2019012776A1 (ja) * | 2017-07-11 | 2019-01-17 | 浜松ホトニクス株式会社 | 試料観察装置及び試料観察方法 |
| TWI659395B (zh) * | 2017-07-19 | 2019-05-11 | AcuSolutions Inc. | 類ｈ＆ｅ影像之合成方法及採用該方法之光學系統 |
| WO2019074926A1 (en) * | 2017-10-09 | 2019-04-18 | Pathspot Technologies Inc. | SYSTEMS AND METHODS FOR DETECTION OF CONTAMINANTS ON SURFACES |
| US10446113B2 (en) * | 2018-01-30 | 2019-10-15 | ForeFlight LLC | Method and system for inversion of raster images |
| US11783603B2 (en) | 2018-03-07 | 2023-10-10 | Verily Life Sciences Llc | Virtual staining for tissue slide images |
| TWI683283B (zh) * | 2018-04-03 | 2020-01-21 | 薩摩亞商銳準醫光股份有限公司 | 一種生物樣本之影像合成方法及採用該方法之光學系統 |
| JP7298993B2 (ja) | 2018-04-09 | 2023-06-27 | 浜松ホトニクス株式会社 | 試料観察装置及び試料観察方法 |
| JP7007227B2 (ja) * | 2018-04-09 | 2022-01-24 | 浜松ホトニクス株式会社 | 試料観察装置及び試料観察方法 |
| US10585042B2 (en) * | 2018-06-06 | 2020-03-10 | Trustees Of Boston University | Systems and methods for imaging microwell plate samples |
| CN110648371B (zh) * | 2018-06-27 | 2023-05-09 | 阿里巴巴集团控股有限公司 | Rgb值与色号信息映射关系的确定方法及装置 |
| JP2021529951A (ja) * | 2018-06-28 | 2021-11-04 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニアＴｈｅ Ｒｅｇｅｎｔｓ Ｏｆ Ｔｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｃａｌｉｆｏｒｎｉａ | 画像データを組み合わせることによる染色組織試料の合成画像の作成 |
| WO2020039520A1 (ja) * | 2018-08-22 | 2020-02-27 | オリンパス株式会社 | 画像処理装置、撮像システム、画像処理装置の作動方法、及び画像処理装置の作動プログラム |
| US12016690B2 (en) * | 2019-02-12 | 2024-06-25 | Purdue Research Foundation | Characterization of injection-induced tissue swelling during subcutaneous injection of biologics |
| CN113424050B (zh) | 2019-02-13 | 2025-01-10 | 文塔纳医疗系统公司 | 用于计算多通道图像中的自体荧光贡献的系统和方法 |
| JP7470339B2 (ja) * | 2019-03-06 | 2024-04-18 | 学校法人 埼玉医科大学 | 染色画像推定器学習装置、画像処理装置、染色画像推定器学習方法、画像処理方法、染色画像推定器学習プログラム、及び、画像処理プログラム |
| EP3709262A1 (en) * | 2019-03-13 | 2020-09-16 | Koninklijke Philips N.V. | Correlated image analysis for 3d biopsy |
| JP7652762B2 (ja) * | 2019-08-28 | 2025-03-27 | ベンタナ メディカル システムズ， インコーポレイテッド | 振動分光法によるバイオマーカー発現の無標識評価 |
| EP4038370A4 (en) * | 2019-10-03 | 2023-10-11 | The Regents of the University of California | Fluorescence imitating brightfield imaging |
| EP3805838B1 (en) * | 2019-10-10 | 2023-12-06 | Leica Instruments (Singapore) Pte. Ltd. | Microscope and related apparatuses, methods and computer programs |
| WO2021081253A1 (en) | 2019-10-22 | 2021-04-29 | Tempus Labs, Inc. | Systems and methods for predicting therapeutic sensitivity |
| KR102302333B1 (ko) * | 2019-11-05 | 2021-09-16 | 주식회사 토모큐브 | 3차원 굴절률 영상과 딥러닝을 활용한 비표지 방식의 3차원 분자 영상 생성 방법 및 장치 |
| US11415571B2 (en) | 2019-12-05 | 2022-08-16 | Tempus Labs, Inc. | Large scale organoid analysis |
| WO2021155378A1 (en) * | 2020-02-01 | 2021-08-05 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Systems and methods for performing multiple-wavelength quantitative phase imaging (qpi) |
| FR3109159B1 (fr) * | 2020-04-09 | 2023-06-23 | Interscience | Procédé de traitement d’images appliqué aux compteurs de colonies en microbiologie |
| US11561178B2 (en) * | 2020-04-20 | 2023-01-24 | Tempus Labs, Inc. | Artificial fluorescent image systems and methods |
| EP3907497B1 (en) * | 2020-05-08 | 2023-08-02 | Leica Microsystems CMS GmbH | Apparatus and method for displaying and/or printing images of a specimen including a fluorophore |
| WO2022030201A1 (ja) * | 2020-08-03 | 2022-02-10 | コニカミノルタ株式会社 | 測光装置 |
| JP7492881B2 (ja) * | 2020-08-03 | 2024-05-30 | 株式会社日本マイクロニクス | 測定システムおよび測定方法 |
| US12251086B2 (en) | 2020-09-03 | 2025-03-18 | University Of Washington | Optical fixation monitor |
| US12014830B2 (en) * | 2021-04-18 | 2024-06-18 | Mary Hitchcock Memorial Hospital, For Itself And On Behalf Of Dartmouth-Hitchcock Clinic | System and method for automation of surgical pathology processes using artificial intelligence |
| CN115656120B (zh) * | 2022-10-09 | 2024-07-23 | 中国科学院深圳先进技术研究院 | 一种暗场反射紫外光学显微成像方法和系统 |
| DE102022130251A1 (de) | 2022-11-16 | 2024-05-16 | Carl Zeiss Microscopy Gmbh | Mikroskopanordnung und Verfahren zur Untersuchung einer mit mehreren Farbstoffen gefärbten Probe |
| WO2025076554A1 (en) * | 2023-10-06 | 2025-04-10 | The Regents Of The University Of California | Targeted cell profiling via in situ hybridization with mass spectrometry detection |
| CN117706102B (zh) * | 2024-02-05 | 2024-04-12 | 遂宁市中心医院 | 一种肿瘤康复用光学检测装置及检测方法 |
Family Cites Families (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4288323A (en) | 1979-02-05 | 1981-09-08 | Brigante Miguel F | Free flow non-corrosive water treatment device |
| US5162990A (en) | 1990-06-15 | 1992-11-10 | The United States Of America As Represented By The United States Navy | System and method for quantifying macrophage phagocytosis by computer image analysis |
| US5249077A (en) | 1991-12-12 | 1993-09-28 | Microvideo Instruments, Inc. | Darkfield illuminator for a microscope slide |
| US6007994A (en) * | 1995-12-22 | 1999-12-28 | Yale University | Multiparametric fluorescence in situ hybridization |
| JP4348574B2 (ja) | 1998-04-30 | 2009-10-21 | 株式会社ニコン | 暗視野照明装置および暗視野照明方法 |
| CA2243090A1 (en) | 1998-07-10 | 2000-01-10 | Timothy M. Richardson | Inverted darkfield contrast microscope and method |
| US8406498B2 (en) * | 1999-01-25 | 2013-03-26 | Amnis Corporation | Blood and cell analysis using an imaging flow cytometer |
| US7450229B2 (en) * | 1999-01-25 | 2008-11-11 | Amnis Corporation | Methods for analyzing inter-cellular phenomena |
| US8131053B2 (en) * | 1999-01-25 | 2012-03-06 | Amnis Corporation | Detection of circulating tumor cells using imaging flow cytometry |
| US6403947B1 (en) | 1999-03-18 | 2002-06-11 | Cambridge Research & Instrumentation Inc. | High-efficiency multiple probe imaging system |
| US6649351B2 (en) | 1999-04-30 | 2003-11-18 | Aclara Biosciences, Inc. | Methods for detecting a plurality of analytes by mass spectrometry |
| AU782408B2 (en) | 1999-05-07 | 2005-07-28 | Yale University | Multiple tag analysis |
| US6195451B1 (en) | 1999-05-13 | 2001-02-27 | Advanced Pathology Ststems, Inc. | Transformation of digital images |
| WO2001008552A1 (en) | 1999-08-03 | 2001-02-08 | Biophysica, Llc | Spectroscopic systems and methods for detecting tissue properties |
| US6649138B2 (en) | 2000-10-13 | 2003-11-18 | Quantum Dot Corporation | Surface-modified semiconductive and metallic nanoparticles having enhanced dispersibility in aqueous media |
| US20020083888A1 (en) | 2000-12-28 | 2002-07-04 | Zehnder Donald A. | Flow synthesis of quantum dot nanocrystals |
| AU2002367778A1 (en) | 2001-07-20 | 2003-11-10 | Quantum Dot Corporation | Luminescent nanoparticles and methods for their preparation |
| DE10144250A1 (de) | 2001-08-31 | 2003-04-03 | Fraunhofer Ges Forschung | Verbesserte massenspektrometrische Analyse unter Verwendung von Nanopartikeln |
| JP2006014868A (ja) * | 2004-06-30 | 2006-01-19 | Hamamatsu Photonics Kk | リンパ節検出装置 |
| US8260013B2 (en) * | 2004-11-22 | 2012-09-04 | Koninklijke Philips Electronics N.V. | Data representation for rtp |
| EP1681015A1 (en) | 2005-01-17 | 2006-07-19 | Imasys SA | Temperature mapping on structural data |
| US7524631B2 (en) * | 2005-02-02 | 2009-04-28 | Patterson Bruce K | HPV E6, E7 mRNA assay and methods of use thereof |
| US8041409B2 (en) * | 2005-09-08 | 2011-10-18 | Carestream Health, Inc. | Method and apparatus for multi-modal imaging |
| KR100708932B1 (ko) | 2005-10-06 | 2007-04-17 | 삼성전기주식회사 | 영상 처리장치 및 그 방법 |
| EP1780672A1 (en) | 2005-10-25 | 2007-05-02 | Bracco Imaging, S.P.A. | Method of registering images, algorithm for carrying out the method of registering images, a program for registering images using the said algorithm and a method of treating biomedical images to reduce imaging artefacts caused by object movement |
| US20090088332A1 (en) | 2005-11-21 | 2009-04-02 | Jingyue Ju | Multiplex Digital Immuno-Sensing Using a Library of Photocleavable Mass Tags |
| US8010184B2 (en) | 2005-11-30 | 2011-08-30 | General Electric Company | Method and apparatus for automatically characterizing a malignancy |
| WO2007064959A2 (en) | 2005-12-01 | 2007-06-07 | Auburn University | High resolution optical microscope |
| CN101351736A (zh) * | 2005-12-27 | 2009-01-21 | 奥林巴斯株式会社 | 发光测量装置及发光测量方法 |
| WO2007074923A1 (ja) | 2005-12-27 | 2007-07-05 | Olympus Corporation | 発光測定装置並びに発光測定方法 |
| JP4614000B2 (ja) * | 2006-04-07 | 2011-01-19 | 株式会社島津製作所 | 質量分析装置 |
| WO2008039758A2 (en) | 2006-09-25 | 2008-04-03 | Cambridge Research & Instrumentation, Inc. | Sample imaging and classification |
| US8244021B2 (en) | 2006-12-20 | 2012-08-14 | Ventana Medical Systems, Inc. | Quantitative, multispectral image analysis of tissue specimens stained with quantum dots |
| US7327859B1 (en) * | 2007-02-14 | 2008-02-05 | Lam Ko Chau | Methods and systems for automated fingerprint recognition |
| JP5013410B2 (ja) * | 2007-03-14 | 2012-08-29 | 独立行政法人産業技術総合研究所 | 微粒子測定方法及び装置 |
| US7819489B2 (en) | 2007-03-20 | 2010-10-26 | Kellogg Company | Concurrently printing an image on a food product and a corresponding image on packaging for the food product |
| US20090129650A1 (en) * | 2007-11-19 | 2009-05-21 | Carestream Health, Inc. | System for presenting projection image information |
| CN101216601B (zh) | 2007-12-29 | 2010-12-15 | 中国科学院西安光学精密机械研究所 | 使用锥镜实现暗场显微及荧光显微的方法及装置 |
| JP4288323B1 (ja) * | 2008-09-13 | 2009-07-01 | 独立行政法人科学技術振興機構 | 顕微鏡装置及びそれを用いた蛍光観察方法 |
| US8849006B2 (en) * | 2009-03-25 | 2014-09-30 | Quorum Technologies Inc. | Darkfield imaging system and methods for automated screening of cells |
| US8948488B2 (en) * | 2009-07-31 | 2015-02-03 | General Electric Company | Methods and systems for digitally enhancing an image of a stained material |
| JP5338573B2 (ja) * | 2009-08-31 | 2013-11-13 | ソニー株式会社 | 蛍光像取得方法、蛍光像取得装置及び蛍光像取得プログラム |
| US8269827B2 (en) * | 2009-09-29 | 2012-09-18 | General Electric Company | System and methods for mapping fluorescent images into a bright field color space |
| EP2601513B1 (en) * | 2010-08-05 | 2014-05-14 | Cambridge Research & Instrumentation, Inc. | Enhancing visual assessment of samples |
-
2010
- 2010-10-07 WO PCT/US2010/051857 patent/WO2011046807A2/en not_active Ceased
- 2010-10-07 US US13/499,959 patent/US9310302B2/en active Active
- 2010-10-07 CN CN201080046023.6A patent/CN102667473B/zh not_active Expired - Fee Related
- 2010-10-07 CA CA2774422A patent/CA2774422C/en not_active Expired - Fee Related
- 2010-10-07 AU AU2010307140A patent/AU2010307140B2/en not_active Ceased
- 2010-10-07 IN IN2337DEN2012 patent/IN2012DN02337A/en unknown
- 2010-10-07 EP EP10823858.5A patent/EP2488860A4/en not_active Withdrawn
- 2010-10-07 KR KR1020127009424A patent/KR101388291B1/ko not_active Expired - Fee Related
- 2010-10-07 JP JP2012533322A patent/JP5540102B2/ja not_active Expired - Fee Related
-
2012
- 2012-03-08 IL IL218553A patent/IL218553B/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| JP2013507612A (ja) | 2013-03-04 |
| CA2774422C (en) | 2017-08-29 |
| AU2010307140B2 (en) | 2014-05-15 |
| EP2488860A4 (en) | 2015-12-16 |
| IL218553B (en) | 2018-01-31 |
| WO2011046807A2 (en) | 2011-04-21 |
| CN102667473A (zh) | 2012-09-12 |
| EP2488860A2 (en) | 2012-08-22 |
| IL218553A0 (en) | 2012-05-31 |
| KR20120066654A (ko) | 2012-06-22 |
| US9310302B2 (en) | 2016-04-12 |
| CN102667473B (zh) | 2016-06-08 |
| IN2012DN02337A (enExample) | 2015-08-21 |
| CA2774422A1 (en) | 2011-04-21 |
| AU2010307140A1 (en) | 2012-04-05 |
| WO2011046807A3 (en) | 2011-09-01 |
| KR101388291B1 (ko) | 2014-04-22 |
| US20120200694A1 (en) | 2012-08-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5540102B2 (ja) | 高められた病理学的決定のための複数モダリティコントラストおよび明視野コンテキスト表現、および組織内の複数検体検出 | |
| EP2601513B1 (en) | Enhancing visual assessment of samples | |
| AU2015318251B2 (en) | System and method for controlling depth of imaging in tissues using fluorescence microscopy under ultraviolet excitation following staining with fluorescing agents | |
| US9964489B2 (en) | System and method for controlling depth of imaging in tissues using fluorescence microscopy under ultraviolet excitation following staining with fluorescing agents | |
| US10846848B2 (en) | System for bright field image simulation | |
| US10032064B2 (en) | Visualization and measurement of cell compartments | |
| JP7418631B2 (ja) | マルチチャネル画像における自己蛍光の寄与を算出するシステムおよび方法 | |
| JP7565621B2 (ja) | 蛍光模倣明視野イメージング | |
| WO2018175565A1 (en) | System and method for controlling depth of imaging in tissues using fluorescence microscopy under ultraviolet excitation following staining with fluorescing agents | |
| US7316904B1 (en) | Automated pap screening using optical detection of HPV with or without multispectral imaging | |
| Levenson et al. | Modern Trends in Imaging X: Spectral Imaging in Preclinical Research and Clinical Pathology | |
| WO2023149296A1 (ja) | 情報処理装置、生体試料観察システム及び画像生成方法 | |
| Levenson et al. | Spectral imaging in preclinical research and clinical pathology | |
| HK1171508A (en) | Multi-modality contrast and brightfield context rendering for enhanced pathology determination and multi-analyte detection in tissue | |
| HK1171508B (en) | Multi-modality contrast and brightfield context rendering for enhanced pathology determination and multi-analyte detection in tissue | |
| BR112012008484A2 (pt) | método, aparelho de formação de imagens, pelo menos um meio de armazenagem legível por computador e processador de imagens | |
| HK40003631A (zh) | 用於明场图像模拟的系统 | |
| HK40003631B (zh) | 用於生成模拟数字明场ihc或ish图像的方法和图像处理系统 | |
| HK1239808A1 (en) | System and method for controlling depth of imaging in tissues using fluorescence microscopy under ultraviolet excitation following staining with fluorescing agents |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20130821 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20130906 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20131126 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20140402 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 5540102 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20140501 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |